Kadimastem Ltd
Kadimastem Ltd (KMSTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KMSTF · as of Jun 9, 2026
Key Statistics
Explore Kadimastem Ltd Data
kmstf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
kmstf competitorsKMSTF
AMHV
ATHJF
EMMLF
NOXOF
OCELStock Performance
Full HistoryAbout Kadimastem Ltd
Kadimastem Ltd an Israeli biopharmaceutical company, focuses on pioneering regenerative medicine therapies that utilize cells originating from human embryonic stem cells, primarily targeting neurodeg…
what is kadimastem ltd · kmstf stock overview · kadimastem ltd company profile · who is kadimastem ltd ceo · kmstf OTC · kadimastem ltd headquarters · kadimastem ltd business segments
About Stock Overview & Key Data
Kadimastem Ltd (KMSTF) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 1, 2021. As of the latest trading session, KMSTF stock price is $3.21, with a market capitalization of $9.5M. The stock has returned -64.61% over the past 12 months and -64.61% year-to-date.
In fiscal year 2024, Kadimastem Ltd reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kadimastem Ltd (KMSTF) stock price is $3.21. The stock is traded on OTC under the ticker symbol KMSTF. The 52-week range is $0.64 – $9.07.